CDKN1A and liver dysplastic nodule: Cell-cycle arrest is a hallmark of MC hypertrophy (Shankland, 1999), and cyclin-dependent kinase inhibitor 1A (CDKN1A), a kind of cyclin-dependent kinase inhibitor, is required for glomerular hypertrophy in experimental DN (Al-Douahji et al., 1999).